Supplementary Figure I: Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma
收藏官方服务：
资源简介：
Hirotsu KE, Rana J, Wang JY, Raghavan SS, Rieger KE, Srinivas S, Fan AC, Kwong BY, Novoa RA, Zaba LC, Clinicopathologic characterization of enfortumab-vedotin associated cutaneous toxicity in patients with urothelial carcinoma, Journal of the American Academy of Dermatology (2021) doi: https://doi.org/10.1016/j.jaad.2020.11.067.
创建时间：
2021-01-04
